Publication | Open Access

Accelerated versus standard cyclophosphamide, epirubicin and5-fluorouracil or cyclophosphamide, methotrexate and5-fluorouracil: a randomized phase III trial in locally advanced breast cancer

Advanced Breast CancerBreast OncologyMedicinePharmacologyBreast CancerPharmacotherapyMethotrexate And5-fluorouracilCancer TreatmentOncologyRadiation OncologyEpirubicin And5-fluorouracil